SaO011A PHASE-I CLINICAL TRIAL OF DONOR-DERIVED MIC CELL INFUSION FOR THE INDUCTION OF DONOR-SPECIFIC HYPORESPONSIVENESS AFTER LIVING DONOR KIDNEY TRANSPLANTATION (TOL-1 STUDY). (18th May 2018) - Morath, Christian; Schmitt, Anita; Kleist, Christian; Daniel, Volker; Opelz, Gerhard; Süsal, Caner; Kälble, Florian; Pego da Silva, Luiza; Sommerer, Claudia; Wang, Lei; Hückelhoven, Angela; Merle, Uta; et al.